VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 43 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,218,500 | -26.1% | 275,000 | +14.6% | 1.39% | -26.4% |
| Q2 2023 | $5,709,600 | +28.2% | 240,000 | +37.1% | 1.88% | +43.2% |
| Q1 2023 | $4,452,000 | -7.6% | 175,000 | +6.1% | 1.32% | -36.1% |
| Q4 2022 | $4,820,000 | -56.1% | 165,000 | -69.2% | 2.06% | -33.2% |
| Q3 2022 | $10,973,000 | +58.1% | 535,000 | -10.8% | 3.08% | -14.8% |
| Q2 2022 | $6,942,000 | -19.5% | 600,000 | +28.6% | 3.62% | +93.2% |
| Q1 2022 | $8,624,000 | -12.8% | 466,403 | -6.7% | 1.87% | -47.1% |
| Q4 2021 | $9,885,000 | +71.7% | 500,000 | +42.9% | 3.54% | +110.3% |
| Q3 2021 | $5,758,000 | -10.1% | 350,000 | 0.0% | 1.68% | -4.3% |
| Q2 2021 | $6,402,000 | +27.7% | 350,000 | +16.7% | 1.76% | +49.4% |
| Q1 2021 | $5,013,000 | – | 300,000 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |